表紙
市場調查報告書

自體免疫疾病診斷的全球市場:2017∼2021年

Global Autoimmune Disease Diagnostics Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 373473
出版日期 內容資訊 英文 134 Pages
訂單完成後即時交付
價格
Back to Top
自體免疫疾病診斷的全球市場:2017∼2021年 Global Autoimmune Disease Diagnostics Market 2017-2021
出版日期: 2016年09月30日內容資訊: 英文 134 Pages
簡介

人體生理學性過程的免疫學的複雜度與自體免疫疾病相關聯。特徵是活化本來的免疫系的慢性發炎過程,及生產破壞自體組織的抗體。全球自體免疫疾病診斷市場,預計2017∼2021年以6.39%的年複合成長率擴大。

本報告提供全球自體免疫疾病診斷市場相關調查,市場現狀及成長預測,市場規模,各地區趨勢,及主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 波特的五力分析

第6章 自體免疫疾病診斷的全球市場:各疾病市場區隔

  • 全身性自體免疫疾病診斷
  • 局部性自體免疫疾病診斷

第7章 自體免疫疾病診斷的全球市場:各產品市場區隔

  • 分析儀
  • 化驗套件

第8章 自體免疫疾病診斷的全球市場:各實驗類型市場區隔

  • ANA
  • CRP
  • 尿液檢查
  • ESR
  • CMP
  • 其他

第9章 自體免疫疾病診斷的全球市場:各終端用戶市場區隔

  • 醫院
  • 診斷及研究實驗室

第10章 自體免疫疾病診斷的全球市場:各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第11章 自體免疫疾病診斷的全球市場:促進要素

  • 新生物標誌物的發現造成自體免疫診斷的改良
  • 實驗室自動化平台的演進
  • M&A的增加
  • 產品認證和上市

第12章 促進要素的影響

第13章 自體免疫疾病診斷的全球市場:課題

  • 自體免疫疾病診斷的限制
  • 免疫化驗套件的標準化與品質相關的重要問題
  • 複數的自體免疫疾病的基本的病因相關理解不足
  • 實施診斷化驗的熟練技術人員不足

第14章 促進要素與課題的影響

第15章 自體免疫疾病診斷的全球市場:趨勢

第16章 供應商環境

  • 競爭模式
  • 主要消息
  • 供應商市場佔有率:2015年

第17章 主要供應商分析

  • Abbott Laboratories
  • Beckman Coulter
  • Bio-Rad Laboratories
  • EUROIMMUN
  • Inova Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare
  • 其他值得注意的供應商

第18章 附錄

第19章 關於Technavio

目錄
Product Code: IRTNTR10562

About the Autoimmune Disease Diagnostics Market

Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.

Technavio's analysts forecast the global autoimmune disease diagnostics market to grow at a CAGR of 6.39% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global autoimmune disease diagnostics market for 2017-2021. To calculate the market size, we use the revenue generated from the sales of various diagnostic tests for autoimmune diseases.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Autoimmune Disease Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Inova Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific

Other Prominent Vendors

  • AESKU Diagnostics
  • Alere
  • Autoimmune Technologies
  • Bio-Diagnostics
  • bioMerieux
  • Diarect
  • DiaSorin
  • Erba Diagnostics
  • Euro Diagnostica
  • EUROIMMUN
  • Exagen Diagnostics
  • Gold Standard Diagnostics
  • HUMAN Diagnostics
  • ImmunArray
  • KRONUS
  • Menarini
  • Myriad Genetics
  • Omega Diagnostics
  • ORGENTEC Diagnostika
  • Protagen
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Seramun Diagnostica
  • SQI Diagnostics
  • Tecan

Market driver

  • Discovery of novel biomarkers
  • For a full, detailed list, view our report

Market challenge

  • Lack of skilled laboratory technicians
  • For a full, detailed list, view our report

Market trend

  • Shift from monoplex to multiplex testing
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Autoimmune diseases

PART 05: Market landscape

  • Market overview
  • Five forces analysis

PART 06: Market segmentation by disease type

  • Systemic autoimmune disease diagnostics
  • Global systemic autoimmune disease market overview
  • Localized autoimmune disease diagnostics
  • Global localized autoimmune disease diagnostics market overview

PART 07: Market segmentation by product type

  • Analyzers
  • Global autoimmune diseases analyzers market overview
  • Assay kits
  • Global autoimmune disease assay kits market overview

PART 08: Market segmentation by test type

  • ANA tests
  • CRP
  • Urinalysis test
  • ESR
  • CMP test
  • Other

PART 09: Market segmentation by end-user

  • Hospitals
  • Diagnostic and research laboratories

PART 10: Geographical segmentation

  • Autoimmune disease diagnostics market in Americas
  • Autoimmune disease diagnostics market in EMEA
  • Autoimmune disease diagnostics market in APAC

PART 11: Market drivers

  • Discovery of novel biomarkers leading to improved autoimmune diagnosis
  • Advancements in laboratory automation platforms
  • Increasing M&A
  • Product approvals and launches

PART 12: Impact of drivers

PART 13: Market challenges

  • Limitation of autoimmune disease diagnostics
  • Significant concerns over standardization and quality of immunoassay kits
  • Lack of understanding on the basic etiology of several autoimmune diseases
  • Shortage of skilled technicians for performing diagnostic assays

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Focus on companion diagnostic tests
  • Shift from monoplex to multiplex testing
  • Collaboration between pharma and diagnostic companies
  • Growing consumer shift toward direct-to-consumer testing

PART 16: Vendor landscape

  • Competitive scenario
  • Key news
  • Vendors market share 2015

PART 17: Key vendor analysis

  • Abbott Laboratories
  • Beckman Coulter
  • Bio-Rad Laboratories
  • EUROIMMUN
  • Inova Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare
  • Other prominent vendors

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

  • Exhibit 01: Product offerings
  • Exhibit 02: Etiology of autoimmune diseases
  • Exhibit 03: Signs and symptoms of autoimmune diseases
  • Exhibit 04: Average annual treatment cost of RA in US and Europe 2014 ($ billions)
  • Exhibit 05: Average annual treatment costs of multiple sclerosis across countries 2014 ($ billions)
  • Exhibit 06: Snapshot of global autoimmune disease diagnostics market 2016-2021
  • Exhibit 07: Global autoimmune disease diagnostics market snapshot
  • Exhibit 08: Key trends in global autoimmune disease diagnostics market
  • Exhibit 09: Global autoimmune disease diagnostics market 2016-2021 ($ millions)
  • Exhibit 10: Opportunity analysis in developed and emerging markets
  • Exhibit 11: Opportunity analysis of global autoimmune diagnostics market
  • Exhibit 12: Five forces analysis
  • Exhibit 13: Global autoimmune disease diagnostics market segmentation by disease type
  • Exhibit 14: Global systemic autoimmune disease diagnostics market 2016
  • Exhibit 15: Global localized autoimmune disease diagnostics market 2016
  • Exhibit 16: Global autoimmune disease diagnostics market segmentation by disease type 2016
  • Exhibit 17: Global autoimmune disease diagnostics market segmentation by disease type 2016
  • Exhibit 18: Antibodies for diagnosis of different systemic autoimmune diseases
  • Exhibit 19: Global systemic autoimmune disease diagnostics market 2016-2021 ($ millions)
  • Exhibit 20: Global RA diagnostics market 2016-2021 ($ millions)
  • Exhibit 21: Prevalence and incidence of SLE
  • Exhibit 22: Global SLE diagnostics market overview 2016-2021 ($ millions)
  • Exhibit 23: Global systemic autoimmune disease diagnostics market measurement parameters
  • Exhibit 24: Opportunity analysis of systemic autoimmune disease market
  • Exhibit 25: Antibodies used for diagnosis of different localized autoimmune diseases
  • Exhibit 26: Global localized autoimmune disease diagnostics market 2016-2021 ($ millions)
  • Exhibit 27: Opportunity analysis of localized autoimmune disease diagnostics market
  • Exhibit 28: Global type 1 diabetes diagnostics market 2016-2021 ($ millions)
  • Exhibit 29: Global autoimmune thyroiditis diagnostics market 2016-2021 ($ millions)
  • Exhibit 30: Global localized autoimmune disease diagnostics market measurement parameters
  • Exhibit 31: Global autoimmune disease diagnostics market segmentation by disease type 2016-2021 ($ millions)
  • Exhibit 32: Global autoimmune disease diagnostics market segmentation by disease type 2016-2021
  • Exhibit 33: Analysis of autoimmune disease diagnostics market segmentation by disease type
  • Exhibit 34: Global autoimmune disease diagnostics market segmentation by product type
  • Exhibit 35: Global autoimmune disease diagnostics market segmentation by product type 2016-2021
  • Exhibit 36: Global autoimmune disease diagnostics market segmentation by product type 2016
  • Exhibit 37: Global autoimmune disease diagnostics market segmentation by product type 2016
  • Exhibit 38: Some of the analyzers developed by vendors
  • Exhibit 39: Global autoimmune diseases analyzers market 2016-2021 ($ millions)
  • Exhibit 40: Opportunity analysis of autoimmune disease analyzers market
  • Exhibit 41: Some of the assays kits available in the market
  • Exhibit 42: Some of the key news related to assay kits
  • Exhibit 43: Global autoimmune diseases assay kits market 2016-2021 ($ millions)
  • Exhibit 44: Opportunity analysis for autoimmune disease assay kits
  • Exhibit 45: Analysis of autoimmune disease diagnostics market by product type
  • Exhibit 46: Global autoimmune disease diagnostics market by product type 2016-2021 ($ millions)
  • Exhibit 47: Global autoimmune disease diagnostics market by product type 2016-2021
  • Exhibit 48: Global autoimmune disease diagnostics market segmentation by test type
  • Exhibit 49: Global autoimmune disease diagnostics market segmentation by test type
  • Exhibit 50: Some of the examples of ANA tests
  • Exhibit 51: Global autoimmune disease diagnostics market segmentation by geography 2016-2021
  • Exhibit 52: Global autoimmune disease diagnostics market segmentation by geography 2016
  • Exhibit 53: Global autoimmune disease diagnostics market segmentation by geography 2016
  • Exhibit 54: Global autoimmune disease diagnostics market segmentation by geography 2016-2021 ($ millions)
  • Exhibit 55: Global autoimmune disease diagnostics market segmentation by geography 2016-2021
  • Exhibit 56: Americas: Market overview of autoimmune disease diagnostics
  • Exhibit 57: Comparison of US healthcare system: Before and after reforms
  • Exhibit 58: Autoimmune disease diagnostics market in Americas 2016-2021 ($ millions)
  • Exhibit 59: Autoimmune disease diagnostics market in EMEA 2016-2021 ($ millions)
  • Exhibit 60: EMEA: Market overview of autoimmune disease diagnostics
  • Exhibit 61: APAC: Market overview of autoimmune disease diagnostics
  • Exhibit 62: Autoimmune disease diagnostics market in APAC 2016-2021 ($ millions)
  • Exhibit 63: Key initiatives of vendors fueling the launch of novel biomarkers
  • Exhibit 64: Key highlights of laboratory automation
  • Exhibit 65: Some of the consolidations witnessed during 2015-2016
  • Exhibit 66: Impact of drivers
  • Exhibit 67: Force field analysis of global autoimmune disease diagnostics market
  • Exhibit 68: Impact of drivers and challenges
  • Exhibit 69: Impact of trends on global autoimmune disease diagnostics market
  • Exhibit 70: Vendors' product development strategy for end-users
  • Exhibit 71: Competitive structure analysis of global autoimmune diagnostics market 2017-2021
  • Exhibit 72: Strategic success factors for companies in global autoimmune disease diagnostics market
  • Exhibit 73: Market penetration analysis of key vendors in autoimmune disease diagnostics 2015
  • Exhibit 74: Vendors' market share breakdown 2015
  • Exhibit 75: Abbott Laboratories: Profile
  • Exhibit 76: Abbott Laboratories: Strength assessment
  • Exhibit 77: Abbott Laboratories: Strategy assessment
  • Exhibit 78: Abbott Laboratories: Opportunity assessment
  • Exhibit 79: Beckman Coulter: Key highlights
  • Exhibit 80: Beckman Coulter: Strength assessment
  • Exhibit 81: Beckman Coulter: Strategy assessment
  • Exhibit 82: Beckman Coulter: Opportunity assessment
  • Exhibit 83: Bio-Rad Laboratories: Key highlights
  • Exhibit 84: Bio-Rad Laboratories: Strength assessment
  • Exhibit 85: Bio-Rad Laboratories: Strategy assessment
  • Exhibit 86: Bio-Rad Laboratories: Opportunity assessment
  • Exhibit 87: EUROIMMUN: Profile
  • Exhibit 88: EUROIMMUN: Strength assessment
  • Exhibit 89: EUROIMMUN: Strategy assessment
  • Exhibit 90: EUROIMMUN: Opportunity assessment
  • Exhibit 91: Inova Diagnostics: Key highlights
  • Exhibit 92: Inova Diagnostics: Strength assessment
  • Exhibit 93: Inova Diagnostics: Strategy assessment
  • Exhibit 94: Inova Diagnostics: Opportunity assessment
  • Exhibit 95: Roche Diagnostics: Key highlights
  • Exhibit 96: Roche Diagnostics: Strength assessment
  • Exhibit 97: Roche Diagnostics: Strategy assessment
  • Exhibit 98: Roche Diagnostics: Opportunity assessment
  • Exhibit 99: Siemens Healthcare: Key highlights
  • Exhibit 100: Siemens Healthcare: Strength assessment
  • Exhibit 101: Siemens Healthcare: Strategy assessment
  • Exhibit 102: Siemens Healthcare: Opportunity assessment
Back to Top